Literature DB >> 22029270

Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide.

Dayanjali Wijesinghe1, Donald M Engelman, Oleg A Andreev, Yana K Reshetnyak.   

Abstract

Drug molecules are typically hydrophobic and small in order to traverse membranes to reach cytoplasmic targets, but we have discovered that more polar molecules can be delivered across membranes using water-soluble, moderately hydrophobic membrane peptides of the pHLIP (pH low insertion peptide) family. Delivery of polar cargo molecules could expand the chemical landscape for pharmacological agents that have useful activity but are too polar by normal drug criteria. The spontaneous insertion and folding of the pHLIP peptide across a lipid bilayer seeks a free energy minimum, and insertion is accompanied by a release of energy that can be used to translocate cell-impermeable cargo molecules. In this study, we report our first attempt to tune the hydrophobicity of a polar cargo, phallacidin, in a systematic manner. We present the design, synthesis, and characterization of three phallacidin cargoes, where the hydrophobicity of the cargo was tuned by the attachment of diamines of various lengths of hydrophobic chains. The phallacidin cargoes were conjugated to pHLIP and shown to selectively inhibit the proliferation of cancer cells in a concentration-dependent manner at low pH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22029270      PMCID: PMC3229090          DOI: 10.1021/bi2009773

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers.

Authors:  Yana K Reshetnyak; Michael Segala; Oleg A Andreev; Donald M Engelman
Journal:  Biophys J       Date:  2007-06-08       Impact factor: 4.033

2.  pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation.

Authors:  Ming An; Dayanjali Wijesinghe; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-03       Impact factor: 11.205

3.  Roles of carboxyl groups in the transmembrane insertion of peptides.

Authors:  Francisco N Barrera; Dhammika Weerakkody; Michael Anderson; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  J Mol Biol       Date:  2011-08-23       Impact factor: 5.469

4.  Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix.

Authors:  J F Hunt; P Rath; K J Rothschild; D M Engelman
Journal:  Biochemistry       Date:  1997-12-09       Impact factor: 3.162

Review 5.  Genomics-based prognosis and therapeutic prediction in breast cancer.

Authors:  Stefanie S Jeffrey; Per Eystein Lønning; Bruce E Hillner
Journal:  J Natl Compr Canc Netw       Date:  2005-05       Impact factor: 11.908

Review 6.  pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.

Authors:  Oleg A Andreev; Donald M Engelman; Yana K Reshetnyak
Journal:  Mol Membr Biol       Date:  2010-10-13       Impact factor: 2.857

7.  Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane.

Authors:  Yana K Reshetnyak; Oleg A Andreev; Michael Segala; Vladislav S Markin; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

8.  pHLIP-mediated translocation of membrane-impermeable molecules into cells.

Authors:  Damien Thévenin; Ming An; Donald M Engelman
Journal:  Chem Biol       Date:  2009-07-31

9.  Design of small-molecule peptidic and nonpeptidic Smac mimetics.

Authors:  Haiying Sun; Zaneta Nikolovska-Coleska; Chao-Yie Yang; Dongguang Qian; Jianfeng Lu; Su Qiu; Longchuan Bai; Yuefeng Peng; Qian Cai; Shaomeng Wang
Journal:  Acc Chem Res       Date:  2008-10       Impact factor: 22.384

10.  A novel technology for the imaging of acidic prostate tumors by positron emission tomography.

Authors:  Amy L Vāvere; Gráinne B Biddlecombe; William M Spees; Joel R Garbow; Dayanjali Wijesinghe; Oleg A Andreev; Donald M Engelman; Yana K Reshetnyak; Jason S Lewis
Journal:  Cancer Res       Date:  2009-05-05       Impact factor: 12.701

View more
  24 in total

1.  Modulation of the pHLIP transmembrane helix insertion pathway.

Authors:  Alexander G Karabadzhak; Dhammika Weerakkody; Dayanjali Wijesinghe; Mak S Thakur; Donald M Engelman; Oleg A Andreev; Vladislav S Markin; Yana K Reshetnyak
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

2.  Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells and Mouse Models.

Authors:  Kelly E Burns; Harvey Hensley; Matthew K Robinson; Damien Thévenin
Journal:  Mol Pharm       Date:  2017-01-13       Impact factor: 4.939

3.  Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.

Authors:  Kelly E Burns; Matthew K Robinson; Damien Thévenin
Journal:  Mol Pharm       Date:  2015-03-13       Impact factor: 4.939

4.  Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.

Authors:  Linden C Wyatt; Anna Moshnikova; Troy Crawford; Donald M Engelman; Oleg A Andreev; Yana K Reshetnyak
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

5.  Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.

Authors:  John C Deacon; Donald M Engelman; Francisco N Barrera
Journal:  Arch Biochem Biophys       Date:  2014-11-18       Impact factor: 4.013

Review 6.  Applications of pHLIP Technology for Cancer Imaging and Therapy.

Authors:  Linden C Wyatt; Jason S Lewis; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Trends Biotechnol       Date:  2017-04-21       Impact factor: 19.536

Review 7.  Considering protonation as a posttranslational modification regulating protein structure and function.

Authors:  André Schönichen; Bradley A Webb; Matthew P Jacobson; Diane L Barber
Journal:  Annu Rev Biophys       Date:  2013-02-28       Impact factor: 12.981

8.  Family of pH (low) insertion peptides for tumor targeting.

Authors:  Dhammika Weerakkody; Anna Moshnikova; Mak S Thakur; Valentina Moshnikova; Jennifer Daniels; Donald M Engelman; Oleg A Andreev; Yana K Reshetnyak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

9.  pH (low) insertion peptide (pHLIP) targets ischemic myocardium.

Authors:  Eugene A Sosunov; Evgeny P Anyukhovsky; Alexander A Sosunov; Anna Moshnikova; Dayanjali Wijesinghe; Donald M Engelman; Yana K Reshetnyak; Oleg A Andreev
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

10.  Targeting ion transport in cancer.

Authors:  E Oosterwijk; R J Gillies
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.